The Fanscotian

Comments (2)

All The Fanscotian Picks Reader Picks Sort: Newest

Your email address will not be published. Required fields are marked *

  • J

    Jordan MetskyMar 21, 2012 at 7:41 pm

    Arielle,
    Before advocating the HPV vaccine for men (and women), you should realize that the long-term effects of the vaccine are still unknown. Merck received approval from the FDA to fast-track Gardasil, which means that the vaccine was not in research and development for the duration of a typical vaccine. This, of course, has been a huge boon to Merck’s vaults. I also hope that you have realized from your research that while HPV is indeed a commonly-transmitted STD, it very rarely develops into a serious illness. This is true of HPV in both men and women according to the CDC. Furthermore, only certain strains of HPV will mutate into cancer. Also, in my experience researching this vaccine, very few patients realize that the vaccine is only effective in its original dosing for about 6 years. I assume, although am not sure, that this applies to men inoculated with Gardasil as well. Before you say that Gardasil requires just “three simple shots,” VAERS data reports that inoculation with Gardasil is correlated to relatively high rates of Guillain Barre syndrome. These rates might not be high enough to discontinue the vaccine, however, to me as a potential consumer, they are definitely something I would want to know about. Wouldn’t you? While I support autonomous vaccine choice, I think it’s important to for people receiving the vaccine to be well-educated on its risks and potential benefits. Patients interested in receiving the vaccination should conduct their own research, as physicians may receive material and financial incentives from Merck to provide certain products. For more information about my views on Gardasil for women, please see my article in the January 2009 edition of the Fanscotian.
    Best,
    Jordan Metsky

    Reply
  • J

    Jordan MetskyMar 21, 2012 at 7:41 pm

    Arielle,
    Before advocating the HPV vaccine for men (and women), you should realize that the long-term effects of the vaccine are still unknown. Merck received approval from the FDA to fast-track Gardasil, which means that the vaccine was not in research and development for the duration of a typical vaccine. This, of course, has been a huge boon to Merck’s vaults. I also hope that you have realized from your research that while HPV is indeed a commonly-transmitted STD, it very rarely develops into a serious illness. This is true of HPV in both men and women according to the CDC. Furthermore, only certain strains of HPV will mutate into cancer. Also, in my experience researching this vaccine, very few patients realize that the vaccine is only effective in its original dosing for about 6 years. I assume, although am not sure, that this applies to men inoculated with Gardasil as well. Before you say that Gardasil requires just “three simple shots,” VAERS data reports that inoculation with Gardasil is correlated to relatively high rates of Guillain Barre syndrome. These rates might not be high enough to discontinue the vaccine, however, to me as a potential consumer, they are definitely something I would want to know about. Wouldn’t you? While I support autonomous vaccine choice, I think it’s important to for people receiving the vaccine to be well-educated on its risks and potential benefits. Patients interested in receiving the vaccination should conduct their own research, as physicians may receive material and financial incentives from Merck to provide certain products. For more information about my views on Gardasil for women, please see my article in the January 2009 edition of the Fanscotian.
    Best,
    Jordan Metsky

    Reply
Activate Search
Young men need HPV, too